Pathway-Targeted Therapies in Cancer 2017
February 19 - 24, 2017
San Francisco CA , Etats-Unis d’Amérique
The recent successes of targeted therapies highlight both the opportunities and the challenges of personalizing cancer care. The combination of diagnostic tools with targeted agents can provide dramatic patient benefits, but improving the durability of clinical responses requires juxtaposition of clinical and pre-clinical studies to address the underlying disease biology. The opportunity provided by this paradigm is exemplified by our ongoing studies with RG7204, an inhibitor of V600E-BRAF.
Lieux de Rendez-Vous
Location: Moscone Convention Center
The Moscone Center is the largest convention and exhibition complex in San Francisco, California. It comprises three main halls: Two underground halls underneath Yerba Buena Gardens, known as..
Contact
747 Howard Street, 5th Flr. San Francisco , USA
415.974.4000, 415.974.4073
Organisateur
Cambridge Healthtech Institute
250 First Avenue
Suite 300
Needham, MA 02494
888-999-6288, 781-972-5400
Evénements Liés
Pathway-Targeted Therapies in Cancer February 19 - 24, 2017
Pathway-Targeted Therapies in Cancer February 9 - 14, 2014
Pathway-Targeted Therapies in Cancer February 23 - 25, 2013
Pathway-Targeted Therapies in Cancer February 19 - 23, 2012